391 related articles for article (PubMed ID: 10706699)
21. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
Nelson D; Bundell C; Robinson B
J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
[TBL] [Abstract][Full Text] [Related]
22. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
23. Multiple paths for activation of naive CD8+ T cells: CD4-independent help.
Wang B; Norbury CC; Greenwood R; Bennink JR; Yewdell JW; Frelinger JA
J Immunol; 2001 Aug; 167(3):1283-9. PubMed ID: 11466344
[TBL] [Abstract][Full Text] [Related]
24. Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model.
Lambrecht BN; Pauwels RA; Fazekas De St Groth B
J Immunol; 2000 Mar; 164(6):2937-46. PubMed ID: 10706680
[TBL] [Abstract][Full Text] [Related]
25. Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres.
Regner M; Martinez X; Belnoue E; Sun CM; Boisgerault F; Lambert PH; Leclerc C; Siegrist CA
J Immunol; 2004 Aug; 173(4):2669-74. PubMed ID: 15294984
[TBL] [Abstract][Full Text] [Related]
26. Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function.
Drake DR; Ream RM; Lawrence CW; Braciale TJ
J Immunol; 2005 Aug; 175(3):1507-15. PubMed ID: 16034088
[TBL] [Abstract][Full Text] [Related]
27. Perforin-independent regulation of dendritic cell homeostasis by CD8(+) T cells in vivo: implications for adaptive immunotherapy.
Ludewig B; Bonilla WV; Dumrese T; Odermatt B; Zinkernagel RM; Hengartner H
Eur J Immunol; 2001 Jun; 31(6):1772-9. PubMed ID: 11385622
[TBL] [Abstract][Full Text] [Related]
28. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
[TBL] [Abstract][Full Text] [Related]
29. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
30. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.
Coles RM; Mueller SN; Heath WR; Carbone FR; Brooks AG
J Immunol; 2002 Jan; 168(2):834-8. PubMed ID: 11777979
[TBL] [Abstract][Full Text] [Related]
31. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
Ehl S; Hombach J; Aichele P; Hengartner H; Zinkernagel RM
J Exp Med; 1997 Apr; 185(7):1241-51. PubMed ID: 9104811
[TBL] [Abstract][Full Text] [Related]
32. Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo.
Manickasingham S; Reis e Sousa C
J Immunol; 2000 Nov; 165(9):5027-34. PubMed ID: 11046031
[TBL] [Abstract][Full Text] [Related]
33. In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma.
Linette GP; Shankara S; Longerich S; Yang S; Doll R; Nicolette C; Preffer FI; Roberts BL; Haluska FG
J Immunol; 2000 Mar; 164(6):3402-12. PubMed ID: 10706736
[TBL] [Abstract][Full Text] [Related]
34. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo.
Kleindienst P; Brocker T
J Immunol; 2003 Mar; 170(6):2817-23. PubMed ID: 12626531
[TBL] [Abstract][Full Text] [Related]
35. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells.
Probst HC; van den Broek M
J Immunol; 2005 Apr; 174(7):3920-4. PubMed ID: 15778347
[TBL] [Abstract][Full Text] [Related]
36. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.
Cao X; Zhang W; He L; Xie Z; Ma S; Tao Q; Yu Y; Hamada H; Wang J
J Immunol; 1998 Dec; 161(11):6238-44. PubMed ID: 9834111
[TBL] [Abstract][Full Text] [Related]
37. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells.
Ho AW; Prabhu N; Betts RJ; Ge MQ; Dai X; Hutchinson PE; Lew FC; Wong KL; Hanson BJ; Macary PA; Kemeny DM
J Immunol; 2011 Dec; 187(11):6011-21. PubMed ID: 22043017
[TBL] [Abstract][Full Text] [Related]
38. Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors.
Hermans IF; Daish A; Yang J; Ritchie DS; Ronchese F
Cancer Res; 1998 Sep; 58(17):3909-17. PubMed ID: 9731502
[TBL] [Abstract][Full Text] [Related]
39. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses.
Bauman SK; Nichols KL; Murphy JW
J Immunol; 2000 Jul; 165(1):158-67. PubMed ID: 10861048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
